LGT Fund Management »

Vertex Pharmaceuticals Incorporated shares owned by LGT Fund Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by LGT Fund Management from 13F filings

Historical chart of LGT Fund Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by LGT Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by LGT Fund Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $603k 1.2k 484.82
2024-12-31 $474k 1.2k 402.70
2024-09-30 $648k 1.4k 462.14
2024-06-30 $637k 1.4k 468.72

More positions owned by LGT Fund Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
salesforce (CRM)
Coca-Cola Company (KO)
Eli Lilly & Co. (LLY)
Blackrock (BLK)
Broadcom (AVGO)
S&p Global (SPGI)

View all positions for LGT Fund Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
FMR
Ubs Global Asset Management Americas
ClearBridge Advisors

View all funds holding Vertex Pharmaceuticals Incorporated